TY - JOUR
T1 - Understanding the Therapeutic Approaches for Neuroprotection
AU - Payal, Nazrana
AU - Sharma, Lalit
AU - Sharma, Aditi
AU - Hobani, Yahya Hosan
AU - Hakami, Mashael Ahmed
AU - Ali, Nemat
AU - Rashid, Summya
AU - Sachdeva, Monika
AU - Gulati, Monica
AU - Yadav, Shivam
AU - Chigurupati, Sridevi
AU - Singh, Abhiav
AU - Khan, Haroon
AU - Behl, Tapan
N1 - Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023
Y1 - 2023
N2 - The term “neurodegenerative disorders” refers to a group of illnesses in which deterioration of nerve structure and function is a prominent feature. Cognitive capacities such as memory and decision-making deteriorate as a result of neuronal damage. The primary difficulty that remains is safeguarding neurons since they do not proliferate or regenerate spontaneously and are therefore not substituted by the body after they have been damaged. Millions of individuals throughout the world suffer from neurodegenerative diseases. Various pathways lead to neurodegeneration, including endoplasmic reticulum stress, calcium ion overload, mitochondrial dysfunction, reactive oxygen species generation, and apoptosis. Although different treatments and therapies are available for neuroprotection after a brain injury or damage, the obstacles are inextricably connected. Several studies have revealed the pathogenic effects of hypothermia, different breathed gases, stem cell treatments, mitochondrial transplantation, multi-pharmacological therapy, and other therapies that have improved neurological recovery and survival outcomes after brain damage. The present review highlights the use of therapeutic approaches that can be targeted to develop and understand significant therapies for treating neurodegenerative diseases.
AB - The term “neurodegenerative disorders” refers to a group of illnesses in which deterioration of nerve structure and function is a prominent feature. Cognitive capacities such as memory and decision-making deteriorate as a result of neuronal damage. The primary difficulty that remains is safeguarding neurons since they do not proliferate or regenerate spontaneously and are therefore not substituted by the body after they have been damaged. Millions of individuals throughout the world suffer from neurodegenerative diseases. Various pathways lead to neurodegeneration, including endoplasmic reticulum stress, calcium ion overload, mitochondrial dysfunction, reactive oxygen species generation, and apoptosis. Although different treatments and therapies are available for neuroprotection after a brain injury or damage, the obstacles are inextricably connected. Several studies have revealed the pathogenic effects of hypothermia, different breathed gases, stem cell treatments, mitochondrial transplantation, multi-pharmacological therapy, and other therapies that have improved neurological recovery and survival outcomes after brain damage. The present review highlights the use of therapeutic approaches that can be targeted to develop and understand significant therapies for treating neurodegenerative diseases.
KW - Neurodegenerative diseases
KW - brain injury/damage
KW - drug targeting
KW - neurodegeneration
KW - oxidative stress
KW - therapeutics
UR - http://www.scopus.com/inward/record.url?scp=85180694896&partnerID=8YFLogxK
U2 - 10.2174/0113816128275761231103102125
DO - 10.2174/0113816128275761231103102125
M3 - Review article
C2 - 38151849
AN - SCOPUS:85180694896
SN - 1381-6128
VL - 29
SP - 3368
EP - 3384
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 42
ER -